NCT00585299已完成不适用
Effects of Weight Loss on Hepatic and Muscle Lipid Content and on Insulin Sensitivity on Obese Adolescents With NAFLD
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 4
- 试验地点
- 2
- 主要终点
- Liver Enzyme, liver and muscle fat content, glucose tolerance status
研究概览
简要总结
To assess whether reversal of fatty liver by moderate weight loss (8% of body weight) will lead to improvements in insulin sensitivity, which will be associated with changes in both glucose status and lipid profiles, in obese children and adolescents with fatty liver who have normal glucose or pre-diabetes.
详细描述
This study will have two groups: one group that eats a moderate calorie, low-fat diet and is weighed regularly (every other week for 16 weeks) and the other who receives traditional diet therapy and returns in 16 weeks. Both groups will undergo procedures that test glucose tolerance and measure liver and muscle fat content before and after study period.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 10 Years 至 21 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •10 to 21 yrs of age
- •Non-smoking
- •BMI >95th percentile for age and gender, but BMI <40
- •Suspicion of fatty liver, with a high ALT (>35)
- •Normal glucose tolerance or prediabetes (impaired glucose tolerance or impaired fasting glucose)
排除标准
- •Females of child-bearing potential who are not using birth control
- •Pregnant or lactating females
- •Current medications except oral anti-diabetic medications and hormonal birth control
- •Lipid-lowering medication that increases liver enzymes
- •Significant kidney dysfunction (creatinine >1.5 mg/dL)
- •Current heavy ethanol use or recent history of binge drinking
- •History or evidence of hepatitis A, B, or C, Wilson's Disease, or alpha-1-antitrypsin deficiency
- •Known to be HIV positive
- •Symptomatic angina pectoris or cardiac insufficiency as defined by the NYHA classification as Functional Class III or IV
- •Major vascular event within 6 months of screening (e.g. MI, stroke)
- •Active cancer within 5 years prior to screening
- •Current systemic disease, including type 1 or 2 diabetes
- •Enrolled in another research study within 1 month prior to screening
- •Implanted paramagnetic material (all subjects will need to fill out the Yale Magnetic Resonance Center safety checklist)
- •Anemia (HCT <35%)
结局指标
主要结局
Liver Enzyme, liver and muscle fat content, glucose tolerance status
时间窗: 16-18 weeks
次要结局
- plasma lipid levels(16-18 weeks)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Liver Health and Metabolic Function in People With ObesityNon-Alcoholic Fatty Liver DiseaseNCT03701828Washington University School of Medicine23
招募中
不适用
Examination of reduction of hepatic fat mass and hepatic fibrosis inhibitory effect of pemafibrate in type 2 diabetic patients with hyperlipidemia and non-alcoholic fatty liverType 2 diabetesJPRN-UMIN000044389Department of Endocrinology and Metabolism, Dokkyo Medical University60
已完成
3 期
Effect of Weight Loss and Exercise on Liver and Muscle Fat in Obese ElderlyObesityNCT00779207Washington University School of Medicine20
已完成
不适用
MR Fat Quantification and Elastography During a Very Low-calorie-ketogenic Diet (Pronokal Method®) vs a Low Calorie DietLiver FatNCT04322110Protein Supplies SL40
已完成
不适用
Impact of Bariatric Surgery on Nonalcoholic Fatty Liver DiseaseNonalcoholic SteatohepatitisNonalcoholic Fatty Liver DiseaseNCT01828528Sheba Medical Center26